Price T Rowe Associates Inc Abcam PLC Transaction History

Price T Rowe Associates Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.54 - $24.41 $36.2 Million - $41.1 Million	-1,682,474 Reduced 49.79%	1,696,778 $38.4 Million
Q2 2023 Aug 14, 2023	SELL	$12.62 - $24.47 $153 Million - $297 Million	-12,125,920 Reduced 78.21%	3,379,252 $82.7 Million
Q1 2023 May 15, 2023	BUY	$12.98 - $17.1 $119 Million - $157 Million	9,191,222 Added 145.57%	15,505,172 $209 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $87.9 Million - $107 Million	6,313,950 New	6,313,950 $98.2 Million
Q2 2022 Aug 15, 2022	BUY	$12.69 - $19.25 $4.11 Million - $6.23 Million	323,670 Added 26.33%	1,553,124 $22.5 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $333,575 - $514,136	21,521 Added 1.78%	1,229,454 $22.5 Million
Q4 2021 Feb 14, 2022	SELL	$20.04 - $23.84 $806,068 - $958,916	-40,223 Reduced 3.22%	1,207,933 $28.4 Million
Q3 2021 Nov 15, 2021	BUY	$17.38 - $21.54 $14,894 - $18,459	857 Added 0.07%	1,248,156 $25.3 Million
Q2 2021 Aug 16, 2021	BUY	$18.47 - $22.11 $363,249 - $434,837	19,667 Added 1.6%	1,247,299 $23.7 Million
Q1 2021 May 17, 2021	BUY	$19.22 - $24.3 $519,362 - $656,634	27,022 Added 2.25%	1,227,632 $23.6 Million
Q4 2020 Feb 16, 2021	BUY	$18.2 - $22.45 $21.9 Million - $27 Million	1,200,610 New	1,200,610 $25.9 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.